BACKGROUND AND AIM: The Krüppel-like transcription factor KLF6 is a novel tumor-suppressor gene. It was inactivated in human prostate cancer and other tumors tissue, as the result of frequent mutation and loss of heterozygosity (LOH). However, there is no data reporting the levels of KLF6 both mRNA and protein in hepatocellular carcinomas (HCCs). We therefore detected mutations and expression of KLF6 in HCC tissues and further observed the effect of it on cell growth in HCC cell lines. METHODS: We analyzed the exon-2 of KLF6 gene by direct DNA sequencing, and detected the expression of KLF6 by RT-PCR and Western blot in 23 HCC tissues and corresponding nontumorous tissues. Loss of growth suppressive effect of the HCC-derived KLF6 mutant was characterized by in vitro growth curves plotted, flow cytometry and Western blotting. RESULTS: KLF6 mutations were found in 2 of 23 HCC tissues and one of mutations was missense. Expression of KLF6 mRNA or protein was down-regulated in 8 (34.7%) or 9 (39.1%) of 23 HCC tissues. Wild-type KLF6 (wtKLF6) inhibited cellular proliferation and prolonged G1-S transition by inducing the expression of p21WAF1 following stable transfection into cultured HepG2 cells, but tumor-derived KLF6 mutant (mKLF6) had no effects. CONCLUSION: Our findings suggest that KLF6 may be involved in pathogenesis of HCC.
BACKGROUND AND AIM: The Krüppel-like transcription factor KLF6 is a novel tumor-suppressor gene. It was inactivated in humanprostate cancer and other tumors tissue, as the result of frequent mutation and loss of heterozygosity (LOH). However, there is no data reporting the levels of KLF6 both mRNA and protein in hepatocellular carcinomas (HCCs). We therefore detected mutations and expression of KLF6 in HCC tissues and further observed the effect of it on cell growth in HCC cell lines. METHODS: We analyzed the exon-2 of KLF6 gene by direct DNA sequencing, and detected the expression of KLF6 by RT-PCR and Western blot in 23 HCC tissues and corresponding nontumorous tissues. Loss of growth suppressive effect of the HCC-derived KLF6 mutant was characterized by in vitro growth curves plotted, flow cytometry and Western blotting. RESULTS:KLF6 mutations were found in 2 of 23 HCC tissues and one of mutations was missense. Expression of KLF6 mRNA or protein was down-regulated in 8 (34.7%) or 9 (39.1%) of 23 HCC tissues. Wild-type KLF6 (wtKLF6) inhibited cellular proliferation and prolonged G1-S transition by inducing the expression of p21WAF1 following stable transfection into cultured HepG2 cells, but tumor-derived KLF6 mutant (mKLF6) had no effects. CONCLUSION: Our findings suggest that KLF6 may be involved in pathogenesis of HCC.
Authors: Pasi A Koivisto; Xiaohui Zhang; Satu-Leena Sallinen; Pauli Sallinen; Heikki J Helin; Jin-Tang Dong; Erwin G Van Meir; Hannu Haapasalo; Eija-Riitta Hyytinen Journal: Int J Cancer Date: 2004-09-10 Impact factor: 7.396
Authors: Daniela A Slavin; Nicolás P Koritschoner; Claudio C Prieto; Fernando J López-Díaz; Bruno Chatton; José Luis Bocco Journal: Oncogene Date: 2004-10-28 Impact factor: 9.867
Authors: Sigal Kremer-Tal; Helen L Reeves; Goutham Narla; Swan N Thung; Myron Schwartz; Analisa Difeo; Amanda Katz; Jordi Bruix; Paulette Bioulac-Sage; John A Martignetti; Scott L Friedman Journal: Hepatology Date: 2004-11 Impact factor: 17.425
Authors: Sharon Benzeno; Goutham Narla; Jorge Allina; George Z Cheng; Helen L Reeves; Michaela S Banck; Joseph A Odin; J Alan Diehl; Doris Germain; Scott L Friedman Journal: Cancer Res Date: 2004-06-01 Impact factor: 12.701
Authors: Alec C Kimmelman; Rui F Qiao; Goutham Narla; Asoka Banno; Nelson Lau; Paula D Bos; Nelson Nuñez Rodriguez; Bertrand C Liang; Abhijit Guha; John A Martignetti; Scott L Friedman; Andrew M Chan Journal: Oncogene Date: 2004-06-24 Impact factor: 9.867
Authors: Jaya Sangodkar; Jiayan Shi; Analisa DiFeo; Rachel Schwartz; Romina Bromberg; Aisha Choudhri; Kim McClinch; Raheleh Hatami; Elias Scheer; Sigal Kremer-Tal; John A Martignetti; Alex Hui; W K Leung; Scott L Friedman; Goutham Narla Journal: Eur J Cancer Date: 2008-12-26 Impact factor: 9.162
Authors: U E Lang; P Kocabayoglu; G Z Cheng; Z Ghiassi-Nejad; U Muñoz; D Vetter; D A Eckstein; R A Hannivoort; M J Walsh; S L Friedman Journal: Oncogene Date: 2012-10-22 Impact factor: 9.867